{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:27:59Z","timestamp":1793125679522,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T00:00:00Z","timestamp":1531872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"No funding was received for this study."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12916-018-1098-3","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T07:07:37Z","timestamp":1530601657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review"],"prefix":"10.1186","volume":"16","author":[{"given":"Thomas","family":"Harder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie J.","family":"Klug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne A. B.","family":"van der Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Wiese-Posselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,18]]},"reference":[{"key":"1098_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/jmv.24746","volume":"89","author":"G Ciccarese","year":"2017","unstructured":"Ciccarese G, Herzum A, Rebora A, Drago F. Prevalence of genital, oral, and anal HPV infection among STI patients in Italy. J Med Virol. 2017;89:1121\u20134.","journal-title":"J Med Virol"},{"issue":"4","key":"1098_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1086\/341782","volume":"186","author":"AR Giuliano","year":"2002","unstructured":"Giuliano AR, Harris R, Sedjo RL, Baldwin S, Roe D, Papenfuss MR, Abrahamsen M, Inserra P, Olvera S, Hatch K. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study. J Infect Dis. 2002;186(4):462\u20139.","journal-title":"J Infect Dis"},{"issue":"2 Suppl","key":"1098_CR3","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.ygyno.2010.01.024","volume":"117","author":"M Stanley","year":"2010","unstructured":"Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol. 2010;117(2 Suppl):S5\u201310.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"1098_CR4","doi-asserted-by":"publisher","first-page":"e79260","DOI":"10.1371\/journal.pone.0079260","volume":"8","author":"U Jaisamrarn","year":"2013","unstructured":"Jaisamrarn U, Castellsague X, Garland SM, Naud P, Palmroth J, Del Rosario-Raymundo MR, Wheeler CM, Salmeron J, Chow SN, Apter D, et al. Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS One. 2013;8(11):e79260.","journal-title":"PLoS One"},{"issue":"2","key":"1098_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/aje\/kwn036","volume":"168","author":"J Koshiol","year":"2008","unstructured":"Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008;168(2):123\u201337.","journal-title":"Am J Epidemiol"},{"issue":"9590","key":"1098_CR6","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890\u2013907.","journal-title":"Lancet"},{"issue":"4","key":"1098_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S1470-2045(05)70086-3","volume":"6","author":"V Cogliano","year":"2005","unstructured":"Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, WHO International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005;6(4):204.","journal-title":"Lancet Oncol"},{"issue":"16","key":"1098_CR8","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1016\/j.ejca.2013.06.033","volume":"49","author":"S de Sanjose","year":"2013","unstructured":"de Sanjose S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, Joura EA, Maldonado P, Laco J, Bravo IG, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49(16):3450\u201361.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1098_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol"},{"issue":"5","key":"1098_CR10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.eururo.2015.12.007","volume":"69","author":"L Alemany","year":"2016","unstructured":"Alemany L, Cubilla A, Halec G, Kasamatsu E, Quiros B, Masferrer E, Tous S, Lloveras B, Hernandez-Suarez G, Lonsdale R, et al. Role of human papillomavirus in penile carcinomas worldwide. Eur Urol. 2016;69(5):953\u201361.","journal-title":"Eur Urol"},{"issue":"4","key":"1098_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/LGT.0b013e31827ed372","volume":"17","author":"M Steinau","year":"2013","unstructured":"Steinau M, Unger ER, Hernandez BY, Goodman MT, Copeland G, Hopenhayn C, Cozen W, Saber MS, Huang Y, Peters ES, et al. Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction. J Low Genit Tract Dis. 2013;17(4):397\u2013403.","journal-title":"J Low Genit Tract Dis"},{"key":"1098_CR12","unstructured":"WHO-IARC: List of classifications by cancer sites with sufficient or limited evidence in humans, Volumes 1 to 121. 2018. https:\/\/monographs.iarc.fr\/ENG\/Classification\/Table4.pdf ."},{"issue":"6","key":"1098_CR13","doi-asserted-by":"publisher","first-page":"djv403","DOI":"10.1093\/jnci\/djv403","volume":"108","author":"X Castellsague","year":"2016","unstructured":"Castellsague X, Alemany L, Quer M, Halec G, Quiros B, Tous S, Clavero O, Alos L, Biegner T, Szafarowski T, et al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst. 2016;108(6):djv403.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"1098_CR14","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/infdis\/jix057","volume":"215","author":"JW Gargano","year":"2017","unstructured":"Gargano JW, Unger ER, Liu G, Steinau M, Meites E, Dunne E, Markowitz LE. Prevalence of genital human papillomavirus in males, United States, 2013-2014. J Infect Dis. 2017;215(7):1070\u20139.","journal-title":"J Infect Dis"},{"issue":"18","key":"1098_CR15","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1097\/01.aids.0000432541.67409.3c","volume":"27","author":"F van Aar","year":"2013","unstructured":"van Aar F, Mooij SH, van der Sande MA, Speksnijder AG, Stolte IG, Meijer CJ, Verhagen DW, King AJ, de Vries HJ, Schim van der Loeff MF. Anal and penile high-risk human papillomavirus prevalence in HIV-negative and HIV-infected MSM. AIDS. 2013;27(18):2921\u201331.","journal-title":"AIDS"},{"issue":"6","key":"1098_CR16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/OLQ.0b013e3181c94a3b","volume":"37","author":"AR Kreimer","year":"2010","unstructured":"Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, Giuliano AR. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis. 2010;37(6):386\u201391.","journal-title":"Sex Transm Dis"},{"issue":"1","key":"1098_CR17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1186\/s12885-017-3678-6","volume":"17","author":"N Buttmann-Schweiger","year":"2017","unstructured":"Buttmann-Schweiger N, Delere Y, Klug SJ, Kraywinkel K. Cancer incidence in Germany attributable to human papillomavirus in 2013. BMC Cancer. 2017;17(1):682.","journal-title":"BMC Cancer"},{"key":"1098_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/1471-2334-10-360","volume":"10","author":"AA Kraut","year":"2010","unstructured":"Kraut AA, Schink T, Schulze-Rath R, Mikolajczyk RT, Garbe E. Incidence of anogenital warts in Germany: a population-based cohort study. BMC Infect Dis. 2010;10:360.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 5","key":"1098_CR19","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1016\/j.cmi.2016.12.017","volume":"22","author":"EA Joura","year":"2016","unstructured":"Joura EA, Pils S. Vaccines against human papillomavirus infections: protection against cancer, genital warts or both? Clin Microbiol Infect. 2016;22(Suppl 5):S125\u20137.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"1098_CR20","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.canep.2014.09.003","volume":"38","author":"B Serrano","year":"2014","unstructured":"Serrano B, Alemany L, Ruiz PA, Tous S, Lima MA, Bruni L, Jain A, Clifford GM, Qiao YL, Weiss T, et al. Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China). Cancer Epidemiol. 2014;38(6):748\u201356.","journal-title":"Cancer Epidemiol"},{"issue":"10030","key":"1098_CR21","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(16)30314-2","volume":"387","author":"KM Schmeler","year":"2016","unstructured":"Schmeler KM, Sturgis EM. Expanding the benefits of HPV vaccination to boys and men. Lancet. 2016;387(10030):1798\u20139.","journal-title":"Lancet"},{"key":"1098_CR22","unstructured":"Guardian T. Give HPV vaccine to boys to protect against cancers, experts say. 2016. https:\/\/www.theguardian.com\/science\/2016\/jul\/09\/vaccine-boys-cancer-men-hpv ."},{"issue":"4","key":"1098_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139. W264","journal-title":"Ann Intern Med"},{"issue":"5","key":"1098_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/OLQ.0000000000000264","volume":"42","author":"JA Kahn","year":"2015","unstructured":"Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML. Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth. Sex Transm Dis. 2015;42(5):246\u201352.","journal-title":"Sex Transm Dis"},{"issue":"7","key":"1098_CR25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/cid\/cir1036","volume":"54","author":"KA Swedish","year":"2012","unstructured":"Swedish KA, Factor SH, Goldstone SE. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. Clin Infect Dis. 2012;54(7):891\u20138.","journal-title":"Clin Infect Dis"},{"key":"1098_CR26","unstructured":"NCT01461096: Evaluating the effectiveness of the quadrivalent human papillomavirus (HPV) vaccine at preventing anal HPV infection in HIV-infected men and women. www.clinicaltrials.gov . Accessed 18 Apr 2017."},{"key":"1098_CR27","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"1098_CR28","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"issue":"4","key":"1098_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380\u20132.","journal-title":"J Clin Epidemiol"},{"issue":"7650","key":"1098_CR30","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"issue":"11","key":"1098_CR31","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1111\/jsm.12670","volume":"11","author":"ER Coskuner","year":"2014","unstructured":"Coskuner ER, Ozkan TA, Karakose A, Dillioglugil O, Cevik I. Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV infection: a randomized study. J Sex Med. 2014;11(11):2785\u201391.","journal-title":"J Sex Med"},{"issue":"5","key":"1098_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1056\/NEJMoa0909537","volume":"364","author":"AR Giuliano","year":"2011","unstructured":"Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011;364(5):401\u201311.","journal-title":"N Engl J Med"},{"issue":"17","key":"1098_CR33","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","volume":"365","author":"JM Palefsky","year":"2011","unstructured":"Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med. 2011;365(17):1576\u201385.","journal-title":"N Engl J Med"},{"issue":"4","key":"1098_CR34","doi-asserted-by":"publisher","first-page":"e93393","DOI":"10.1371\/journal.pone.0093393","volume":"9","author":"KA Swedish","year":"2014","unstructured":"Swedish KA, Goldstone SE. Prevention of anal condyloma with quadrivalent human papillomavirus vaccination of older men who have sex with men. PLoS One. 2014;9(4):e93393.","journal-title":"PLoS One"},{"issue":"5","key":"1098_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1503\/cmaj.070948","volume":"177","author":"L Rambout","year":"2007","unstructured":"Rambout L, Hopkins L, Hutton B, Fergusson D. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ. 2007;177(5):469\u201379.","journal-title":"CMAJ"},{"issue":"50","key":"1098_CR36","doi-asserted-by":"publisher","first-page":"8352","DOI":"10.1016\/j.vaccine.2007.09.027","volume":"25","author":"G La Torre","year":"2007","unstructured":"La Torre G, de Waure C, Chiaradia G, Mannocci A, Ricciardi W. HPV vaccine efficacy in preventing persistent cervical HPV infection: a systematic review and meta-analysis. Vaccine. 2007;25(50):8352\u20138.","journal-title":"Vaccine"},{"issue":"7","key":"1098_CR37","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/IGC.0b013e3181a3d100","volume":"19","author":"LR Medeiros","year":"2009","unstructured":"Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC, Zanini RR. Efficacy of human papillomavirus vaccines: a systematic quantitative review. Int J Gynecol Cancer. 2009;19(7):1166\u201376.","journal-title":"Int J Gynecol Cancer"},{"key":"1098_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-11-13","volume":"11","author":"B Lu","year":"2011","unstructured":"Lu B, Kumar A, Castellsague X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 2011;11:13.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1098_CR39","first-page":"483","volume":"110","author":"L Rey-Ares","year":"2012","unstructured":"Rey-Ares L, Ciapponi A, Pichon-Riviere A. Efficacy and safety of human papilloma virus vaccine in cervical cancer prevention: systematic review and meta-analysis. Arch Argent Pediatr. 2012;110(6):483\u20139.","journal-title":"Arch Argent Pediatr"},{"issue":"10","key":"1098_CR40","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","volume":"12","author":"T Malagon","year":"2012","unstructured":"Malagon T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(10):781\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"35\u201336","key":"1098_CR41","first-page":"584","volume":"111","author":"Y Delere","year":"2014","unstructured":"Delere Y, Wichmann O, Klug SJ, van der Sande M, Terhardt M, Zepp F, Harder T. The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis. Dtsch Arztebl Int. 2014;111(35\u201336):584\u201391.","journal-title":"Dtsch Arztebl Int"},{"issue":"21","key":"1098_CR42","first-page":"4153","volume":"19","author":"G Capra","year":"2015","unstructured":"Capra G, Nyitray AG, Lu B, Perino A, Marci R, Schillaci R, Matranga D, Firenze A, Caleca M, Bellavia C, et al. Analysis of persistence of human papillomavirus infection in men evaluated by sampling multiple genital sites. Eur Rev Med Pharmacol Sci. 2015;19(21):4153\u201363.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"1098_CR43","doi-asserted-by":"publisher","first-page":"e015867","DOI":"10.1136\/bmjopen-2017-015867","volume":"7","author":"M Lehtinen","year":"2017","unstructured":"Lehtinen M, Lagheden C, Luostarinen T, Eriksson T, Apter D, Harjula K, Kuortti M, Natunen K, Palmroth J, Petaja T, et al. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials. BMJ Open. 2017;7(8):e015867.","journal-title":"BMJ Open"},{"issue":"7","key":"1098_CR44","doi-asserted-by":"publisher","first-page":"e68329","DOI":"10.1371\/journal.pone.0068329","volume":"8","author":"R Herrero","year":"2013","unstructured":"Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One. 2013;8(7):e68329.","journal-title":"PLoS One"},{"issue":"8","key":"1098_CR45","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/infdis\/jiw359","volume":"214","author":"LA Pinto","year":"2016","unstructured":"Pinto LA, Kemp TJ, Torres BN, Isaacs-Soriano K, Ingles D, Abrahamsen M, Pan Y, Lazcano-Ponce E, Salmeron J, Giuliano AR. Quadrivalent human papillomavirus (HPV) vaccine induces HPV-specific antibodies in the oral cavity: results from the mid-adult male vaccine trial. J Infect Dis. 2016;214(8):1276\u201383.","journal-title":"J Infect Dis"},{"issue":"5","key":"1098_CR46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","volume":"15","author":"M Drolet","year":"2015","unstructured":"Drolet M, Benard E, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JM, Cummings T, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(5):565\u201380.","journal-title":"Lancet Infect Dis"},{"key":"1098_CR47","unstructured":"Wilkin TJ, Chen H, Cespedes M, Paczuski P, Godfrey C, Chiao E, Luque A, Webster-Cyriaque JY, Bastow B, Cranston R, et al. ACTG A5298: a phase 3 trial of the quadrivalent HPV vaccine in older HIV+ adults. In: Conference on Retroviruses and Opportunistic Infections. Session O-14. Boston: Conference on Retroviruses and Opportunistic Infections Foundation; 2016."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-018-1098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-018-1098-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-018-1098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T18:17:09Z","timestamp":1661537829000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-018-1098-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,18]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1098"],"URL":"https:\/\/doi.org\/10.1186\/s12916-018-1098-3","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,18]]},"assertion":[{"value":"8 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"110"}}